| For: | Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, Voelker M, Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 2006; 12(21): 3338-3343 [PMID: 16733849 DOI: 10.3748/wjg.v12.i21.3338] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i21/3338.htm |
| Number | Citing Articles |
| 1 |
Katarzyna Zdanowicz, Monika Kowalczuk-Kryston, Witold Olanski, Irena Werpachowska, Wlodzimierz Mielech, Dariusz Marek Lebensztejn. Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents—A Preliminary Study. Biomolecules 2022; 12(5) doi: 10.3390/biom12050710
|
| 2 |
Pamela Valva, Daniela A Ríos, Elena De Matteo, Maria V Preciado. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World Journal of Gastroenterology 2016; 22(4): 1367-1381 doi: 10.3748/wjg.v22.i4.1367
|
| 3 |
Piotr Adrian Klimiuk, Izabela Domysławska, Stanisław Sierakowski, Justyna Chwiećko. Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockers. Rheumatology International 2015; 35(4) doi: 10.1007/s00296-014-3112-1
|
| 4 |
Gloria Sanchez-Antolín, Carolina Almohalla-Alvarez, Pilar Bueno, Raquel Almansa, Verónica Iglesias, Lucia Rico, Alicia Ortega, Eva Muñoz-Conejero, Felix García-Pajares, Jesus F. Bermejo-Martin, Matias A Avila. Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis. PLOS ONE 2015; 10(8) doi: 10.1371/journal.pone.0137128
|
| 5 |
Joanna M. Łotowska, Dariusz M. Lebensztejn. Immunoreactive hepatic stellate cells in biopsy material in children with chronic hepatitis B. The first report in pediatric patients. Polish Journal of Pathology 2015; 66(3) doi: 10.5114/pjp.2015.54955
|
| 6 |
Lorena Zuliani-Alvarez, Anna M. Piccinini. A virological view of tenascin-C in infection. American Journal of Physiology-Cell Physiology 2023; 324(1) doi: 10.1152/ajpcell.00333.2022
|
| 7 |
Morten A. Karsdal, Kim Henriksen, Federica Genovese, Diana J. Leeming, Mette J. Nielsen, Bente J. Riis, Claus Christiansen, Inger Byrjalsen, Detlef Schuppan. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes. Diabetologia 2017; 60(1) doi: 10.1007/s00125-016-4094-1
|
| 8 |
|
| 9 |
M Kasprzycka, C Hammarström, G Haraldsen. Tenascins in fibrotic disorders—from bench to bedside. Cell Adhesion & Migration 2015; 9(1-2) doi: 10.4161/19336918.2014.994901
|
| 10 |
Judith Flores-Calderón, Segundo Morán-Villota, Guillermo Ramón-García, Berenice González-Romano, María del Carmen Bojórquez-Ramos, Laura Cerdán-Silva, Pablo Hernández-Frías. Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study. Annals of Hepatology 2012; 11(3) doi: 10.1016/S1665-2681(19)30933-0
|
| 11 |
Yue Chen, Jia‑En Yang, Jing‑Mo Tang, Qian‑Guo Mao, Qi‑Zhong Zheng, Ying Zheng. Predictive value of plasmacytoid dendritic cells and Toll‑like receptor‑9 regarding the treatment efficacy of interferon‑α in HBeAg‑positive chronic hepatitis B patients. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8161
|
| 12 |
Solange Heller, Pedro Valencia-Mayoral. Treatment of Viral Hepatitis in Children. Archives of Medical Research 2007; 38(6) doi: 10.1016/j.arcmed.2006.09.005
|
| 13 |
Martin Degen, Florence Brellier, Susanne Schenk, Robert Driscoll, Khalil Zaman, Roger Stupp, Luigi Tornillo, Luigi Terracciano, Ruth Chiquet‐Ehrismann, Curzio Rüegg, Walter Seelentag. Tenascin‐W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients. International Journal of Cancer 2008; 122(11) doi: 10.1002/ijc.23417
|
| 14 |
Valdas Banys, Goda Aleknavičiūtė-Valienė. Clinical importance of laboratory biomarkers in liver fibrosis. Biochemia medica 2022; 32(3) doi: 10.11613/BM.2022.030501
|
| 15 |
K. Patel, Y. Benhamou, E. M. Yoshida, K. D. Kaita, S. Zeuzem, M. Torbenson, E. Pulkstenis, G. M. Subramanian, J. G. McHutchison. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C. Journal of Viral Hepatitis 2009; 16(3) doi: 10.1111/j.1365-2893.2008.01062.x
|
| 16 |
Pamela Valva, Paola Casciato, Juan M. Diaz Carrasco, Adrian Gadano, Omar Galdame, María Cristina Galoppo, Eduardo Mullen, Elena De Matteo, María Victoria Preciado, Ravi Jhaveri. The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic Infection. PLoS ONE 2011; 6(8) doi: 10.1371/journal.pone.0023218
|
| 17 |
Andrea Sabina Llera, Maria Romina Girotti, Lorena Gabriela Benedetti, Osvaldo Luis Podhajcer. Matricellular proteins and inflammatory cells: A task force to promote or defeat cancer?. Cytokine & Growth Factor Reviews 2010; 21(1) doi: 10.1016/j.cytogfr.2009.11.010
|